dc.contributor.author |
Kanz, Lothar |
|
dc.date.accessioned |
2015-10-13T11:51:28Z |
|
dc.date.available |
2015-10-13T11:51:28Z |
|
dc.date.issued |
2015 |
|
dc.identifier.issn |
0887-6924 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/65509 |
|
dc.language.iso |
en |
de_DE |
dc.publisher |
Nature Publishing Group |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1038/leu.2015.36 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20150901145020_00879 |
|
utue.publikation.seiten |
1123-1132 |
de_DE |
utue.personen.roh |
Kalmanti, L. |
|
utue.personen.roh |
Saussele, S. |
|
utue.personen.roh |
Lauseker, M. |
|
utue.personen.roh |
Mueller, M. C. |
|
utue.personen.roh |
Dietz, C. T. |
|
utue.personen.roh |
Heinrich, L. |
|
utue.personen.roh |
Hanfstein, B. |
|
utue.personen.roh |
Proetel, U. |
|
utue.personen.roh |
Fabarius, A. |
|
utue.personen.roh |
Krause, S. W. |
|
utue.personen.roh |
Rinaldetti, S. |
|
utue.personen.roh |
Dengler, J. |
|
utue.personen.roh |
Falge, C. |
|
utue.personen.roh |
Oppliger-Leibundgut, E. |
|
utue.personen.roh |
Burchert, A. |
|
utue.personen.roh |
Neubauer, A. |
|
utue.personen.roh |
Kanz, L. |
|
utue.personen.roh |
Stegelmann, F. |
|
utue.personen.roh |
Pfreundschuh, M. |
|
utue.personen.roh |
Spiekermann, K. |
|
utue.personen.roh |
Scheid, C. |
|
utue.personen.roh |
Pfirrmann, M. |
|
utue.personen.roh |
Hochhaus, A. |
|
utue.personen.roh |
Hasford, J. |
|
utue.personen.roh |
Hehlmann, R. |
|
dcterms.isPartOf.ZSTitelID |
Leukemia |
de_DE |
dcterms.isPartOf.ZS-Issue |
5 |
de_DE |
dcterms.isPartOf.ZS-Volume |
29 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |